Malignant Diseases of The Lung: Neuroendocrine Tumors of Lung

Travis W.D. Advances in neuroendocrine lung tumors. Ann. Oncol. 2010;21:ii65–ii71. doi: 10.1093/annonc/mdq380.

Rekhtmann N. Neuroendocrine tumors of the lung. Arch. Pathol. Lab. Med. 2010;134:1628–1638.

Bertino E.M. Pulmonary neuroendocrine/carcinoid tumors. Cancer. 2009;115:4434–4441. doi: 10.1002/cncr.24498.

WHO Classification of Tumours of the Lung, Pleura, Thymus, and Heart, 4th ed, Travis WD, Brambilla E, Burke AP, et al. (Eds), IARC, Lyon 2015.

Valente M., Catena L., Milione M., Pusceddu S., Formisano B., Bajetta E. Common diagnostic challenges in the histopathologic diagnosis of neuroendocrine lung tumors: A case report. Case Rep. Oncol. 2010;3:202–207. doi: 10.1159/000317313.

Hauso O, Gustafsson BI, Kidd M, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 2008; 113:2655.

Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97:934.

Dasari A, Shen C, Halperin D, et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol 2017; 3:1335.

Thomas Jr.CF,Jett JR, Strosberg JR. Lung neuroendocrine (carcinoid) tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging. [(accessed on 28 May 2020)]. Available online: https://www.uptodate.com/contents/lung-neuroendocrine-carcinoid-tumors-epidemiology-risk-factors-classification-histology-diagnosis-and-staging?search=neuroendocrine%20tumors%20of%20lung&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1

Riley L, Sutchu S, Lu L, Urbine D. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: An Asthma Mimicker. Am J Med 2020; 133:e199.

Carr LL, Chung JH, Duarte Achcar R, et al. The clinical course of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Chest 2015; 147:415.

Halperin DM, Shen C, Dasari A, et al. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study. Lancet Oncol 2017; 18:525.

Fisseler-Eckhoff A, Demes M. Neuroendocrine tumors of the lung. Cancers (Basel). 2012;4(3):777-798. Published 2012 Jul 31. doi:10.3390/cancers4030777

Bakhshayesh Karam M., Zahirifard S., Tahbaz M.O., Kaynama K., Tolou F., Jabari Darjani H. Bronchial carcinoid tumors: Clinical and radiological findings in 21 patients. J. Thorac. Cardiovasc. Surg. 2005;2:111–116.

Taal B.G., Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrin. 2004;80:3–7. doi: 10.1159/000080731.

Bertino E.M. Pulmonary neuroendocrine/carcinoid tumors. Cancer. 2009;115:4434–4441. doi: 10.1002/cncr.24498

Sayeg Y., Bonnet R. Neuroendocrine tumors of the lung. [(accessed on 20 February 2012)]. Available online: http://www.rhoen-klinikumag.com/rka/cms/zbb_2/deu/download/Neuroendocrine_Tumors_of_the_Lung.pdf.

Aron M, Kapila K, Verma K. Carcinoid tumors of the lung: a diagnostic challenge in bronchial washings. Diagn Cytopathol 2004; 30:62.

Kurul IC, Topçu S, Taştepe I, et al. Surgery in bronchial carcinoids: experience with 83 patients. Eur J Cardiothorac Surg 2002; 21:883.

Travis WD, Brambilla E, Burke AP, et al. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. Lyon, France: International Agency for Research on Cancer, 2015.

Corrin B, Nicholson AG. Pathology of the Lungs. 3rd ed. London, England: Churchill Livingstone Elsevier, 2011.

Marchevsky AM, Wirtschafter E, Walts AE. The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH? Hum Pathol 2015;46:176-81.

Oshiro Y, Kusumoto M, Matsuno Y, et al. CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients. AJR Am J Roentgenol 2004;182:87-91.

Hiroshima K, Iyoda A, Shida T, et al. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical and molecular analysis. Mod Pathol 2006;19:1358-68

Travis WD. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod Pathol 2012;25:S18-S30.

Nicholson SA, Beasley MB, Brambilla E, et al. Small cell lung carcinoma (SCLC) A Clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002;26:1184-97.

Kalemkerian GP, Akerley W, Bogner P, et al. Small cell lung cancer: Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2013;11:78-98

Caplin ME, Baudin E, Ferolla P, et al. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol 2015;26:1604-20.

Hilal T. Current understanding and approach to well differentiated lung neuroendocrine tumors: an update on classification and management. Therapeutic Advances in Medical Oncology 2017;9:189-99.

Filosso PL, Ferolla P, Guerrera F, et al. Multidisciplinary management of advanced lung neuroendocrine tumors. J Thorac Dis 2015;7(Suppl 2):S163-S171.

Fasano M, Corte CMD, Papaccio F, et al. Pulmonary large cell neuroendocrine carcinoma From epidemiology to therapy. J Thor Oncol 2015;10:1133-41

Zacharias J, Nicholson AG, Ladas GP, et al. Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systeatic nodal disection. Ann Thorac Surg 2003;75:348-52.

Veronesi G, Morandi U, Alloisio M, et al. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Lung Cancer 2006;53:111-5

Rossi G, Cavazza A, Marchioni A, et al. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGRRβ, PDGFRα, and Met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol 2006;34:8775-85.

Derks JL, Suylen RJV, Thunnissen E, et al. Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter? Eur Respir J 2017;49(6). pii: 1601838. doi: 10.1183/13993003.01838-2016.

Nicholson SA, Beasley MB, Brambilla E, et al. Small cell lung carcinoma (SCLC) A Clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002;26:1184-97.

Daddi N, Schiavon M, Filosso PL, et al. Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids. Eur J Cardiothorac Surg 2014;45:677-86.

Iyoda A, Jiang SX, Travis WD, et al. Clinicopathologic features and the impact of the new TNM classification of malignant tumors in patients with pulmonary large cell neuroendocrine carcinoma. Mol Clin Oncol 2013;1:437-43.

Tanaka Y, Ogawa H, Uchino K, et al. Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: A possible association between staining patterns with neuroendocrne markers and tumor response to chemotherapy. J Thorac Cardiovasc Surg 2013;145:839-46.